Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1990
A146 ROUTINE APPLICATION OF HIGH-DOSE APROTININ IN OPEN-HEART SURGERY- A STUDY ON 1,784 PATIENTS
Inst. for Anesthesiology, German Heart Center Munich, FRG The application of the proteinase inhibitor aprotinin may considerably reduce bleeding in open-heart surgery (1–4). To study the clinical effectiveness and safety of aprotinin we evaluated the data of 1,784 consecutive patients with and without aprotinin treatment prospectively.
Anesthesiology September 1990, Vol. 73, NA.
Citation
W. Dietrich, J. A. Richter; A146 ROUTINE APPLICATION OF HIGH-DOSE APROTININ IN OPEN-HEART SURGERY- A STUDY ON 1,784 PATIENTS. Anesthesiology 1990; 73:NA doi: https://doi.org/10.1097/00000542-199009001-00145
Download citation file:
Citing articles via
Most Viewed
Related Articles
Cost-Benefit and Efficacy of Aprotinin Compared with ε-Aminocaproic Acid in Patients Having Repeated Cardiac Operations : A Randomized, Blinded Clinical Trial
Anesthesiology (December 1997)
The Effects of Aprotinin on Thromboelastography with Three Different Activators
Anesthesiology (November 2001)
Anaphylactic Reactions to Aprotinin Reexposure in Cardiac Surgery: Relation to Antiaprotinin Immunoglobulin G and E Antibodies
Anesthesiology (July 2001)
Effects of Aprotinin Dosage on Renal Function: An Analysis of 8,548 Cardiac Surgical Patients Treated with Different Dosages of Aprotinin
Anesthesiology (February 2008)
Comparison of Blood-conservation Strategies in Cardiac Surgery Patients at High Risk for Bleeding
Anesthesiology (March 2000)
